SCHEMBL4448545

SCHEMBL4448545

CS(=O)(=O)OC1(NCl)CCCCCC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4454081 0.71
SCHEMBL5936147 0.67 NPSR1 (0.34) NPSR1
SCHEMBL27701284 0.67 CA1 (0.33) NPSR1
SCHEMBL8378199 0.65
SCHEMBL30974668 0.64 NPSR1 (0.50) NPSR1
SCHEMBL27701261 0.64 NPSR1 (0.31) NPSR1
SCHEMBL10408099 0.64
SCHEMBL19285249 0.62
SCHEMBL17869535 0.62 NPSR1 (0.35) NPSR1
SCHEMBL20640581 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120965-B1 N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES NOVABAY PHARMACEUTICALS INC (US) 2014-11-05 EP disclosed
EP-2120965-A1 N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES Novabay Pharmaceuticals, Inc. (US) 2009-11-25 EP disclosed
WO-2008083347-A1 N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES NOVABAY PHARMACEUTICALS, INC. (US) 2008-07-10 WO disclosed